Belgium· BE-AMP-SAM660855-00
Alopexy 50 mg/ml
A minoxidil product containing minoxidil, registered in Belgium by PI Pharma. The same ATC class is registered in 14 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Minoxidil is registered in 14 of 19 countries.
Countries holding a registration under ATC D11AX01 (minoxidil), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Minoxidil · ATC D11AX01
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Minoxidil
- Manufacturer
- PI Pharma
- Country
- Belgium (BE)
- ATC code
- D11AX01
- ATC class
- Minoxidil
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb4667408
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
44 interactions on record for minoxidil.
Graded by severity as the source publishes them — 44 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Minoxidil · interactions on record
44 records
- 44 moderate
Most severe, free to view
- PapaverineA03AD01moderate
- SapropterinA16AX07moderate
- EpoprostenolB01AC09moderate
- IloprostB01AC11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Minoxidil in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United States5% MINOXIDIL TOPICAL SolutionNanhong (Zhuhai) Biotechnology Co., Ltd.
- SpainALOPEXY 50 mg/ml SOLUCION CUTANEAPierre Fabre Iberica S.A.
- NetherlandsHGS Minoxidil 50 mg/ml oplossing voor cutaan gebruikMAE Holding B.V.
- FinlandMinoxidil OrionOrion Corporation
- SwedenMinoxidil ABECE Forte 50 mg/ml Kutan lösningEvolan Pharma AB
- PolandAgrociaMedical Valley Invest AB
- SwitzerlandMinoxidil Leman 50 mg/ml, solution pour application cutanéeLeman SKL SA
- FranceALOPEXY 50 mg/ml, solution pour application cutanéePIERRE FABRE MEDICAMENT
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Alocutan, Alopexy
- Bulgaria · Регаин, Регаин Пяна За Жени
- Cyprus · Androxil, Botafex
- Czechia · Belohair, Minorga
- Germany · Alopexy, Lonolox
- Denmark · Lotorin, Minoxidil Intermed
- Estonia · Regaine, Tricovivax
- Spain · Alocutan, Aloxidil
- Finland · Lotorin, Minoxidil Orion
- France · Alopexy, Alostil
- United Kingdom (Northern Ireland) · Loniten, Minoxidil
- Greece · Alopexy, Androxil
- Croatia · Alomax, Regaine
- Hungary · Brillaton, Minoxidil Miowell
- Ireland · Loniten, Minoxidil For Men Careforsons Ireland
- Italy · Aloxidil, Carexidil
- Lithuania · Minoxidil Auxilia, Minoxidil Inteli
- Luxembourg · Alopexy, Minoxidil Biorga
- Latvia · Minoxidil Auxilia, Minoxidil Inteli
- Malta · Minorga, Minoxidil Nio
- Netherlands · Lonnoten, Minoxidil Bipharma
- Norway · Minoksidil Norfri, Recrea Forte
- Poland · Agrocia, Alocutan
- Portugal · Alorexyl, Folcare
- Romania · Alopexy, Hairgrow
- Sweden · Lotorin, Minoxidil Abece
- Slovenia · Regaine, Regaine Za Ženske
- Slovakia · Minorga, Minoxidil Miowell
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ec98a81f-1c66-4d16-8566-6e7b8ffd4597 GET /v1/drugs/ec98a81f-1c66-4d16-8566-6e7b8ffd4597?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Cutaneous solution",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Alopexy 50 mg/ml",
"name_fr": "Alopexy 50 mg/ml",
"name_nl": "Alopexy 50 mg/ml",
"amp_code": "SAM660855-00",
"strengths": [
"50.0000",
"50.0000"
],
"pack_count": 2,
"substances": [
"Minoxidil",
"Ethanol 96%",
"Propylene Glycol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Minoxidil",
"authorisation_numbers": [
"1637PI0613F007"
]
}See everything about minoxidil.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.